The tarsal plate manifestation of IgG4-related disease.

Int Ophthalmol

Department of Orbital Surgery, The Rotterdam Eye Hospital, P.O. Box 70030, 3000 LM, Rotterdam, The Netherlands.

Published: July 2019

AI Article Synopsis

  • - A 58-year-old woman was diagnosed with IgG4-related disease in her upper eyelids, characterized by swelling and ulceration, confirmed by biopsy showing increased IgG4-positive plasma cells
  • - The patient's serum IgG4 levels were elevated and specialized imaging revealed significant activity localized to her eyelids
  • - Treatment with oral and topical steroids resulted in substantial improvement of the eyelid lesions, indicating effective management of this specific condition

Article Abstract

Purpose: To describe a clinical case of bilateral biopsy-proven IgG4-related disease confined to the tarsal plate.

Method: Interventional case report.

Results: A 58-year-old woman presented with a tarsal swelling in the lateral part of the upper eyelids, with focal ulceration and mucus. Histology revealed fibrotic inflammation with increased IgG4-positive plasma cells fulfilling the criteria of IgG4-related disease (IgG4-RD). Serum IgG4 levels were increased, and pathological fluorodeoxyglucose uptake at positron emission tomography/CT scanning was restricted to the upper eyelids. After treatment with oral and topical prednisone, the tarsal lesions markedly regressed.

Conclusions: Periorbital IgG4-RD may be confined to the tarsal plate. Treatment with systemic and topical steroids may induce significant regression.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10792-018-0974-3DOI Listing

Publication Analysis

Top Keywords

igg4-related disease
12
tarsal plate
8
confined tarsal
8
upper eyelids
8
tarsal
5
plate manifestation
4
manifestation igg4-related
4
disease purpose
4
purpose describe
4
describe clinical
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!